These insights provide a deeper understanding of the interplay between zinc signaling, GPR39 activity, and hormonal regulation in bone biology, suggesting that targeting GPR39 could offer novel therapeutic strategies for bone disorders characterized by impaired matrix composition and remodeling, such as osteoporosis. Here, GPR39 is linked to bone disorder.